Abstract - (2021) Volume 7, Issue 7
Hyper-active GSK-3β favors Tau phosphorylation during the progression of Alzheimer disease (AD). Akt is one of the main kinases inhibiting GSK-3β and its activation occurs in response to neurotoxic stimuli including, i.e., oxidative stress. Biliverdin reductase-A (BVR-A) is a scaffold protein favoring the Akt-mediated inhibition of GSK-3β. Interestingly, reduced BVR-A levels along with increased
oxidative stress were observed early in the hippocampus of 3xTg-AD mice (at 6 months), thus suggesting that loss of BVR-A could be a limiting factor in the oxidative stress-induced Akt-mediated inhibition of GSK-3β in AD. In this study we evaluated changes in the level of BVR-A, Akt, GSK-3β, oxidative stress and Tau phosphorylation (1) in young (6-months) and old (12-months) 3xTg-AD mice; and (2) in post-mortem IPL samples from MCI, AD and age-matched controls. Furthermore, similar analyses were performed in vitro in cells lacking BVR-A and treated with H2O2. In result we have found reduced BVR-A levels along with (1) increased oxidative stress; (2) reduced GSK-3β inhibition and (3) increased Tau Ser404 (target of GSK-3β activity) phosphorylation without changes of Akt activation both in young mice and in MCI, were observed. Interestingly, cells lacking BVR-A and treated with H2O2 showed reduced GSK-3β inhibition and increased Tau Ser404 phosphorylation, which resulted from a defect of Akt and GSK-3β physical interaction. Reduced levels of Akt/GSK-3β complex were confirmed in young 3xTg-AD and MCI. Conclusively here we demonstrate that loss of BVR-A levels but not in its activity impairs the neuroprotective Akt-mediated inhibition of GSK-3β in response to oxidative stress, thus contributing to Tau hyper-phosphorylation in early stage AD.
Copyright: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
